AWG
AMLX icon

Alpha Wave Global’s Amylyx Pharmaceuticals AMLX Stock Holding History

Alpha Wave Global’s Portfolio AMLX Stock Details AMLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.79M Buy
155,422
+13,086
+9% +$202K 0.04% 20
2026
Q1 		$1.98M Sell
142,336
-175,342
-55% -$2.47M 0.25% 15
2025
Q4 		$3.84M Sell
317,678
-9,634
-3% -$131K 0.47% 14
2025
Q3 		$4.45M Buy
327,312
+51,470
+19% +$484K 0.45% 18
2025
Q2 		$1.77M Buy
275,842
+88,531
+47% +$431K 0.19% 27
2025
Q1 		$663K Buy
187,311
+38,684
+26% +$138K 0.3% 19
2024
Q4 		$562K Sell
148,627
-520,860
-78% -$2.45M 0.26% 19
2024
Q3 		$2.17M Buy
+669,487
New +$1.5M 0.67% 15
2024
Q1 		– Sell
-846,240
Closed -$12.5M – 28
2023
Q4 		$12.5M Sell
846,240
-7,022
-0.8% -$108K 6.01% 6
2023
Q3 		$15.6M Hold
853,262
– – 9.88% 4
2023
Q2 		$18.4M Sell
853,262
-77,075
-8% -$2.08M 12.06% 2
2023
Q1 		$27.3M Buy
930,337
+109,117
+13% +$3.79M 10.08% 2
2022
Q4 		$30.3M Buy
821,220
+120,585
+17% +$4.28M 5.54% 5
2022
Q3 		$19.7M Hold
700,635
– – 2.33% 9
2022
Q2 		$13.5M Buy
700,635
+83,415
+14% +$990K 1.39% 17
2022
Q1 		$7.93M Buy
+617,220
New +$13.9M 0.71% 35

Other funds holding AMLX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Alpha Wave Global's AMLX Position: Q2 2026 in Review

Alpha Wave Global increased its Amylyx Pharmaceuticals (AMLX) stake by 9.2% in Q2 2026, buying an estimated $202K and bringing the position to 155,422 shares worth $2.79M. The position accounts for 0.04% of the portfolio, ranked #20.

Alpha Wave Global first reported a position in AMLX in Q1 2022 and has held it in 16 quarters since. The position peaked at $30.3M in Q4 2022. 207 funds tracked by Wall St. Rank hold AMLX as of Q2 2026.

  • Alpha Wave Global held 155,422 shares of Amylyx Pharmaceuticals worth $2.79M as of Q2 2026.
  • Alpha Wave Global bought 13,086 Amylyx Pharmaceuticals shares in Q2 2026, an estimated $202K.
  • Amylyx Pharmaceuticals made up 0.04% of Alpha Wave Global's portfolio in Q2 2026, its #20 holding.
  • Alpha Wave Global first reported a position in Amylyx Pharmaceuticals in Q1 2022 and has held it in 16 quarters since.
  • Alpha Wave Global's Amylyx Pharmaceuticals position peaked at $30.3M in Q4 2022.
  • 207 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q2 2026.

Based on Alpha Wave Global's 13F filing for Q2 2026, filed 13 Aug 2026.